Shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.25 and traded as low as $4.99. Syros Pharmaceuticals shares last traded at $5.00, with a volume of 68,625 shares trading hands. Analyst Upgrades and Downgrades […]
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report)‘s stock had its “overweight” rating reiterated by Piper Sandler in a research note issued on Wednesday, Benzinga reports. They presently have a $13.00 price objective on the stock. Piper Sandler’s price target indicates a potential upside of 166.94% from the stock’s current price. Other analysts have also recently […]
Syros Pharmaceuticals (NASDAQ:SYRS) Lifted to Hold at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Insider Sells $29,024 60 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokerages that […]